BDNF Expression and Breast Cancer Outcomes
Author Information
Author(s): Neill Patani, Wen G Jiang, Kefah Mokbel
Primary Institution: The London Breast Institute, The Princess Grace Hospital
Hypothesis
The study aims to determine the mRNA and protein expression of BDNF in breast cancer and its correlation with pathological parameters and clinical outcomes.
Conclusion
Higher BDNF expression levels in breast cancer specimens are significantly associated with poorer clinical outcomes and adverse pathological parameters.
Supporting Evidence
- BDNF expression was significantly higher in breast cancer tissues compared to normal tissues.
- Higher BDNF levels were associated with local recurrence and death from breast cancer.
- BDNF emerged as an independent prognostic variable for disease-free survival.
Takeaway
This study found that a protein called BDNF is more common in breast cancer tissues than in normal tissues, and having more of it is linked to worse health outcomes.
Methodology
The study involved RNA extraction and reverse transcription from breast cancer tissues, followed by real-time quantitative PCR to measure BDNF expression levels.
Potential Biases
Potential bias due to the use of background tissue from cancer patients instead of healthy individuals.
Limitations
Using normal tissue from breast cancer patients for comparison may not accurately reflect true normal tissue, and a larger cohort may have influenced results that approached significance.
Participant Demographics
Women with breast cancer, with a sample size of 127 for cancer tissues and 33 for normal tissues.
Statistical Information
P-Value
p = 0.007
Confidence Interval
95% CI = 107.49-143.24
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website